386 filings
EFFECT
SPRC
SciSparc Ltd
25 Jun 24
Notice of effectiveness
12:15am
POS AM
SPRC
SciSparc Ltd
17 Jun 24
Prospectus update (post-effective amendment)
4:05pm
6-K
SPRC
SciSparc Ltd
14 Jun 24
Report of Foreign Private Issuer
4:00pm
6-K
SPRC
SciSparc Ltd
3 Jun 24
SciSparc Secures Strategic Advantage with Grant of European Patent
7:13am
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
425
pqzqkv
2 May 24
Business combination disclosure
4:46pm
6-K
7jqcj rl0op6f50tuixx
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
20-F/A
tcoft62
2 May 24
Annual report (foreign) (amended)
9:18am
425
yd2p4mmw8ueb
12 Apr 24
Business combination disclosure
9:23am
6-K
r7rkbw60 gaq3mu6a
11 Apr 24
Agreement and Plan of Merger
4:05pm
S-8
rin7uy cllb3c
1 Apr 24
Registration of securities for employees
5:11pm
6-K
tuo pgyxp5egn72y
27 Mar 24
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
9:18am
6-K
jbvqin5ogj
15 Mar 24
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
8:00am
6-K
b8yts3uk18 ui6gyngol
13 Mar 24
Report of Foreign Private Issuer
9:06am
6-K
znfx6luynxo44t3tr2m
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
EFFECT
xu59p
7 Mar 24
Notice of effectiveness
12:15am
6-K
rt1 8j28c
29 Feb 24
Report of Foreign Private Issuer
9:07am
F-1
guhjjyimb
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
pt6l49jzxfbbr3jer6p0
27 Feb 24
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
8:35am